This editorial webinar moves downstream to clinical development, as several advancements in technology are changing the way we view clinical trials, including remote monitoring solutions. Also, tools like wearables are moving studies away from a central site location, in both virtual and hybrid models.
With use cases across the drug development continuum, AI also is being used to improve clinical trial recruitment, pharmacovigilance, safety, and risk management as the industry collects data from more sources than ever before.
